GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (NAS:AZTA) » Definitions » E10

AZTA (Azenta) E10 : $4.05 (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Azenta E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Azenta's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $4.05 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Azenta's average E10 Growth Rate was -5.80% per year. During the past 3 years, the average E10 Growth Rate was 43.20% per year. During the past 5 years, the average E10 Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Azenta was 80.00% per year. The lowest was -4.20% per year. And the median was 43.20% per year.

As of today (2024-12-13), Azenta's current stock price is $45.94. Azenta's E10 for the quarter that ended in Sep. 2024 was $4.05. Azenta's Shiller PE Ratio of today is 11.34.

During the past 13 years, the highest Shiller PE Ratio of Azenta was 1307.00. The lowest was 9.36. And the median was 37.81.


Azenta E10 Historical Data

The historical data trend for Azenta's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta E10 Chart

Azenta Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.39 1.38 4.16 4.30 4.05

Azenta Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.30 4.25 4.08 4.04 4.05

Competitive Comparison of Azenta's E10

For the Medical Instruments & Supplies subindustry, Azenta's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Azenta's Shiller PE Ratio falls into.



Azenta E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Azenta's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.1/133.0289*133.0289
=-0.100

Current CPI (Sep. 2024) = 133.0289.

Azenta Quarterly Data

per share eps CPI Adj_EPS
201412 -0.040 99.070 -0.054
201503 0.040 99.621 0.053
201506 0.110 100.684 0.145
201509 0.100 100.392 0.133
201512 -0.070 99.792 -0.093
201603 -1.220 100.470 -1.615
201606 0.120 101.688 0.157
201609 0.150 101.861 0.196
201612 0.200 101.863 0.261
201703 0.200 102.862 0.259
201706 0.250 103.349 0.322
201709 0.250 104.136 0.319
201712 0.230 104.011 0.294
201803 0.950 105.290 1.200
201806 0.320 106.317 0.400
201809 0.150 106.507 0.187
201812 0.200 105.998 0.251
201903 0.050 107.251 0.062
201906 0.100 108.070 0.123
201909 5.690 108.329 6.987
201912 0.180 108.420 0.221
202003 0.120 108.902 0.147
202006 0.190 108.767 0.232
202009 0.390 109.815 0.472
202012 0.350 109.897 0.424
202103 0.320 111.754 0.381
202106 0.530 114.631 0.615
202109 0.290 115.734 0.333
202112 0.580 117.630 0.656
202203 28.280 121.301 31.014
202206 -0.130 125.017 -0.138
202209 -0.280 125.227 -0.297
202212 -0.150 125.222 -0.159
202303 -0.070 127.348 -0.073
202306 -0.020 128.729 -0.021
202309 0.060 129.860 0.061
202312 -0.280 129.419 -0.288
202403 -2.470 131.776 -2.493
202406 -0.120 132.554 -0.120
202409 -0.100 133.029 -0.100

Add all the adjusted EPS together and divide 10 will get our e10.


Azenta  (NAS:AZTA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Azenta's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=45.94/4.05
=11.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Azenta was 1307.00. The lowest was 9.36. And the median was 37.81.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Azenta E10 Related Terms

Thank you for viewing the detailed overview of Azenta's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Azenta Business Description

Traded in Other Exchanges
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Executives
Herman Cueto officer: EVP, Chief Financial Officer C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
Violetta Hughes officer: VP, Chief Accounting Officer C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
Ginger Zhou officer: SVP and General Manager, Genom 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Jason Joseph officer: VP, General Counsel, Secretary 170 TRACER LANE, WALTHAM MA 02451
David C Gray officer: Chief Strategy & New Business C/O GT SOLAR INTERNATIONAL, INC., 243 DANIEL WEBSTER HIGHWAY, MERRIMACK NH 03054
Joseph R Martin director
Dorothy E Puhy director DANA FARBER CANCER INSTITUTE, 44 BINNEY STREET, RM. D1632, BOSTON MA 02115
Tina Susan Nova director C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Mitchell Coyne officer: SVP and GM, Life Sciences Proj 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Matthew Mcmanus officer: EVP & Chief Operating Officer 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Lindon G Robertson officer: EVP & Chief Financial Officer C/O GRAFTECH INTERNATIONAL LTD., 12900 SNOW ROAD, PARMA OH 44130
Kimberly Crowley officer: Chief Human Resources Officer 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Vandana Sriram officer: VP, Finance & Corp. Controller 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Jesus Linda De officer: Chief Commercial Officer, LS 15 ELIZABETH DRIVE, CHEMSFORD MA 01824
David Jarzynka officer: Sr. VP, General Manager 15 ELIZABETH DRIVE, CHELMSFORD MA 01824